#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thermal burn Pustular psoriasis Amyotrophic lateral sclerosis Prader-Willi syndrome Haemophilia A without inhibitors Neuromyelitis optica spectrum disorder Methylmalonic acidaemia Choroidal dystrophy Neuropathic arthropathy Congenital growth hormone deficiency Arginase deficiency Philadelphia chromosome positive Hairy cell leukaemia recurrent Neurodevelopmental disorder Sarcoma More trials…

    Learn about Rare Diseases

    Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Ehlers-Danlos syndrome – Trials in Disease Rett syndrome – Trials in Disease Isodicentric chromosome 15 syndrome – Trials in Disease Phenylketonuria – Treatment Mucopolysaccharidosis Glomerulonephritis rapidly progressive – Treatment Soft tissue sarcoma – Diagnostics Pleural mesothelioma malignant – Diagnostics Sarcoidosis – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000030825 Doxribtimine Demeclocycline Hydrochloride Ifosfamide Hydrocortisone Hemisuccinate Immunoglobulin G Viltolarsen Deupirfenidone Phenprocoumon Serpina1(Human)-Aav8-1 Spartalizumab Garadacimab Hydrocortisone SP16 Lithium Sulphate, Anhydrous RIMIDUCID Dobutamine Hydrochloride ALENDRONATE SODIUM TRIHYDRATE Zipalertinib Golimumab More therapies…

    Learn about Your Condition

    Endometrial cancer stage I Langerhans' cell histiocytosis Hepatotoxicity Pituitary tumour benign Neoplasm malignant Atrophic vulvovaginitis Neurofibrosarcoma Thrombosis Intracranial aneurysm Craniocerebral injury Metastatic gastric cancer Hyperkalaemia Acute myeloid leukaemia BK virus infection Diabetic autonomic neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of ASP2957 Gene Therapy for Male Patients with X-linked Myotubular Myopathy Who Require Breathing Support with Ventilators

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Congenital myopathy
    Investigated Drugs:
    • ASP2957
    France

  • Study of morphine to relieve shortness of breath in patients with amyotrophic lateral sclerosis who have breathing problems

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Morphine Sulfate
    France

  • Study of Tildrakizumab for Eye Problems in Patients with Lyell Syndrome

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Toxic epidermal necrolysis
    Investigated Drugs:
    • Tildrakizumab
    France

  • Testing Gene Therapy AAV9/AP4M1 in Patients with Hereditary Spastic Paraplegia Type 50

    Not yet recruiting

    2 1 1
    Italy

  • Study of SP16 to Prevent Acute Kidney Injury in Patients with Chronic Kidney Disease Undergoing Heart Surgery with Heart-Lung Machine

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Mitral valve disease
    • Arteriosclerosis coronary artery
    • Chronic kidney disease
    Investigated Drugs:
    • SP16
    Germany

  • Study of palonosetron and fosaprepitant to prevent nausea and vomiting after laparoscopic surgery

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Prophylaxis of nausea and vomiting
    Investigated Drugs:
    • Fosaprepitant
    • Ondansetron
    • Palonosetron
    Sweden
Previous Page
1 … 752 753 754 755 756 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!